Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Announcement / 2026-04-07 Semiconductors
  • [Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2026-02-09 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Other Corporate Matters (Voluntary Disclosure) / 2026-03-30 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Paid-in Capital Increase Decision of Subsidiary / 2025-01-08 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Hana Securities | 2Q24 Consensus Beat Preview · 2024/2025 Earnings Upgraded · Target Price Raised / 2024-07-11 RESEARCH
  • [Disclosure] Celltrion (068270) – Additional Listing (Stock Dividend) / 2025-04-11 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Decision on Debt Guarantee for Others / 2026-03-20 Disclosures
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Legacy Memory Deceleration · Relative HBM Stability · Hold Rating Maintained / 2024-10-25 RESEARCH

Category: Disclosures

[Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Eydenzelt (CT-P42, Eylea Biosimilar) / 2025-02-14

Posted on February 14, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Eydenzelt (CT-P42, Eylea Biosimilar) / 2025-02-14

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received final marketing authorization from the European Commission (EC) for Eydenzelt (CT-P42), a biosimilar to Eylea, covering major ophthalmic indications across 30 European countries. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of EC Marketing Authorization Listing in…

Read More “[Disclosure] Celltrion (068270) – Approval of European Commission Marketing Authorization for Eydenzelt (CT-P42, Eylea Biosimilar) / 2025-02-14” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Advance Notice of Financial Results Disclosure / 2025-02-14

Posted on February 14, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Advance Notice of Financial Results Disclosure / 2025-02-14

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it expects to disclose its tentative financial results for FY2024 (2024-01-01 to 2024-12-31) on February 25, 2025. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of FY2024 Preliminary Financial Results Disclosure This disclosure serves as official…

Read More “[Disclosure] Celltrion (068270) – Advance Notice of Financial Results Disclosure / 2025-02-14” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Electronics (005930) – Delisting from Foreign Securities Market / 2025-02-13

Posted on February 13, 2025July 29, 2026 By K-STOCK Editor
[Disclosure] Samsung Electronics (005930) – Delisting from Foreign Securities Market / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electronics announced the trading termination and delisting of 1,567,644 Preferred Depositary Receipts (DRs) from the Luxembourg Stock Exchange due to low trading volume. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Overseas DR Delisting and Reflection in…

Read More “[Disclosure] Samsung Electronics (005930) – Delisting from Foreign Securities Market / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] Samsung Electronics (005930) – Listing on Foreign Securities Market / 2025-02-13

Posted on February 13, 2025July 29, 2026 By K-STOCK Editor
[Disclosure] Samsung Electronics (005930) – Listing on Foreign Securities Market / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electronics announced that it has relisted 1,567,644 Preferred Depositary Receipts (DRs) on the London Stock Exchange (LSE), transferring them from the Luxembourg Stock Exchange. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Overseas DR Relisting and Reflection…

Read More “[Disclosure] Samsung Electronics (005930) – Listing on Foreign Securities Market / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Matters Related to Timely Disclosure Obligations (Fair Disclosure) / 2025-02-13

Posted on February 13, 2025August 1, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Matters Related to Timely Disclosure Obligations (Fair Disclosure) / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This fair disclosure outlines the company’s plan to retire 1,302,059 treasury shares (1.35% of total issued shares, valued at approximately KRW 130B) in May 2025 to enhance shareholder value. 📊 [Key Disclosure Contents & Summary of Major Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Formal…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Matters Related to Timely Disclosure Obligations (Fair Disclosure) / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Corporations) / 2025-02-13

Posted on February 13, 2025August 1, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Corporations) / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Driven by booming AI semiconductor investment and strong demand for HBM equipment, FY2024 consolidated revenue surged by 251.5% YoY to KRW 558.9B and operating profit jumped by 638.7% YoY to KRW 255.4B. Net profit declined due to a decrease in valuation gains on financial assets. 📊…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Corporations) / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – Resolution on Convening of Annual General Meeting of Shareholders / 2025-02-13

Posted on February 13, 2025August 2, 2026 By K-STOCK Editor
[Disclosure] HPSP (403870) – Resolution on Convening of Annual General Meeting of Shareholders / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP has decided to hold its Annual General Meeting of Shareholders on March 28, 2025, to vote on the approval of FY2024 financial statements (including a dividend of KRW 600 per share), the re-election of directors and audit committee members, and the director remuneration limit. 📊…

Read More “[Disclosure] HPSP (403870) – Resolution on Convening of Annual General Meeting of Shareholders / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – Decision on Cash and In-Kind Dividend / 2025-02-13

Posted on February 13, 2025August 2, 2026 By K-STOCK Editor
[Disclosure] HPSP (403870) – Decision on Cash and In-Kind Dividend / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP has decided to pay a year-end cash dividend of KRW 600 per common share for FY2024, totaling approximately KRW 48.22B. 📊 [Key Disclosure Contents & Summary Metrics] 1. Dividend Overview 2. Dividend Per Share & Total Amount 3. Key Dates and Approval Authority 📝 Editor’s…

Read More “[Disclosure] HPSP (403870) – Decision on Cash and In-Kind Dividend / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – Decision on Disposal of Treasury Stocks / 2025-02-13

Posted on February 13, 2025August 2, 2026 By K-STOCK Editor
[Disclosure] HPSP (403870) – Decision on Disposal of Treasury Stocks / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP has decided to dispose of 4,290 treasury common shares (valued at approximately KRW 132.13M) via direct account transfer to fulfill its employee Restricted Stock Unit (RSU) compensation plan. 📊 [Key Disclosure Contents & Summary Metrics] 1. Shares and Amount to be Disposed 2. Purpose and…

Read More “[Disclosure] HPSP (403870) – Decision on Disposal of Treasury Stocks / 2025-02-13” »

Semiconductors, Disclosures

[Disclosure] Celltrion (068270) – Approval of Korean MFDS Marketing Authorization for Avtozma Subcutaneous Injection (CT-P47, Actemra Biosimilar) / 2025-02-13

Posted on February 13, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Approval of Korean MFDS Marketing Authorization for Avtozma Subcutaneous Injection (CT-P47, Actemra Biosimilar) / 2025-02-13

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received marketing authorization from the Ministry of Food and Drug Safety (MFDS) of South Korea for Avtozma Subcutaneous Injection (CT-P47), a biosimilar referencing Actemra, for the treatment of rheumatoid arthritis. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Read More “[Disclosure] Celltrion (068270) – Approval of Korean MFDS Marketing Authorization for Avtozma Subcutaneous Injection (CT-P47, Actemra Biosimilar) / 2025-02-13” »

Disclosures, Bio & Healthcare

Posts pagination

Previous 1 … 150 151 152 … 252 Next
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – Hana | HBM4 · LTA · Valuation Appeal / 2026-07-30 RESEARCH
  • [Disclosure] Celltrion (068270) – Rulings on Lawsuit (Correction) / 2025-07-11 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2024-04-30 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract (Correction) / 2024-09-24 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Final Issue Price for Rights Issue / 2025-06-27 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Business Transfer / 2026-01-28 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Execution of Single Sales or Supply Contract / 2025-12-22 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme